A detailed history of Syon Capital LLC transactions in Ardelyx, Inc. stock. As of the latest transaction made, Syon Capital LLC holds 19,893 shares of ARDX stock, worth $121,944. This represents 0.01% of its overall portfolio holdings.

Number of Shares
19,893
Holding current value
$121,944
% of portfolio
0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$4.49 - $6.85 $89,319 - $136,267
19,893 New
19,893 $101 Million
Q4 2023

Feb 02, 2024

BUY
$3.29 - $6.64 $127,981 - $258,296
38,900 New
38,900 $241 Million

Others Institutions Holding ARDX

About ARDELYX, INC.


  • Ticker ARDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 154,636,000
  • Market Cap $948M
  • Description
  • Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...
More about ARDX
Track This Portfolio

Track Syon Capital LLC Portfolio

Follow Syon Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Syon Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Syon Capital LLC with notifications on news.